# Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

> **NCT02567149** · PHASE2 · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Warts

## Interventions

- **DRUG:** Cidofovir

## Key facts

- **NCT ID:** NCT02567149
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02567149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02567149, "Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02567149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*